Bi/ond is a brand that combines expertise in microelectronics with biological solutions to make individualized medicine a reality. With a strong focus on bridging the gap between biology and engineering, Bi/ond provides tools and lab technology for more accurate drug testing and simulations of any tissue type. Their innovative approach is rooted in the belief that every person is unique, and their medicines should reflect that.

Bi/ond collaborates with top European hospitals, technical institutes, and research centers, and their products, such as inCHIPit™, MUSbit™, and comPLATE™, are used by professionals in the field. The team at Bi/ond, led by CEO and co-founder Dr. Cinzia Silvestri, is committed to shortening the distance between academia and industry and aims to develop inclusive and precise cures for all.

With a multidisciplinary team of experts in microelectronics, biology, and cell biology, Bi/ond is making significant strides in the organ-on-chip field to revolutionize drug testing and personalized medicine